'Checkpoint inhibitors' show promise in cancer fight
In 2010, metastatic melanoma roared into Julius Rauch's lungs and spine, no longer tamable using conventional treatments. With maybe four months left to live, Rauch got into a clinical trial of an experimental drug.
Julia Carpenter, Washington Post
Kathleen Felton, Washington Post
Dan Diamond and Riley Beggin, Washington Post
Dear Abby, Inquirer wire services
David Murphy | Columnist






















